Search

everythinglearnresearchcommunity

for

Search:↓

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Hair follicle-derived melanocyte transplant could effectively treat vitiligo by restoring skin color.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Treg cells help repair and regenerate tissues by interacting with local cells.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Early regulatory T cells are crucial for normal skin pigmentation.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Older skin has higher cancer risk due to inflammation and stem cell issues.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

The conclusion is that the cornea has two types of stem cells, with Lrig1+ cells being key for renewal in aging corneas, independent of CD44.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

Blocking LFA-1 prevents hair loss in mice.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Exosomes from certain cells can improve hair regrowth by changing the immune response.